menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Genomics' ×
Forrest Anthony
FDA unanimously recommends approving this gene altering therapy for pediatric lymphoblastic leukemia.
Read More
Forrest Anthony
Brad Smith
Helena Zhang
How the Chinese Society of Clinical Oncology is helping to turn China into a world-class destination for oncology research Oncology research has become a hot topic for biopharma companies in China, in large part due to the growing epidemic of cancer resulting from increased tobacco use, unhealthy lifestyles, and the aging population. As I’ve noted in previous blogs, one-third of global lung cancer cases and approximately one-half of all diagnoses of gastric, liver, and esophageal cancer cases now occur in China, and improving outcomes for these patients has become a priority for the government and for the industry. One organization that is driving the fight against cancer in China is the Chinese Society of Clinical Oncology (CSCO). CSCO is a professional group made up of...
Read More
John Doyle
Jennifer Christian
Win Shaw
A primer on different kinds of biomarkers and how these tools are enabling precision medicine.
Read More
Brad Smith
Can industry attract more oncology patients into genotype-matched trials?
Read More
Terry Murdock
Looking ahead to the preeminent oncology meeting of the year.
Read More
Eric Groves
Five challenges of delivering immuno-oncology trials and how to overcome them.
Read More